Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
August 31, 2026 -119.23M
May 31, 2026 -102.54M
February 28, 2026 -75.96M
November 30, 2025 -67.30M
August 31, 2025 -95.31M
May 31, 2025 -126.49M
February 28, 2025 -83.70M
November 30, 2024 -92.11M
August 31, 2024 -81.70M
May 31, 2024 -59.65M
February 29, 2024 -50.78M
November 30, 2023 -44.23M
August 31, 2023 16.58M
May 31, 2023 -12.69M
February 28, 2023 -70.31M
Date Value
November 30, 2022 -100.02M
August 31, 2022 -149.30M
May 31, 2022 -209.57M
February 28, 2022 -215.99M
November 30, 2021 -196.57M
August 31, 2021 -216.32M
December 31, 2020 -179.10M
September 30, 2020 -263.81M
June 30, 2020 -318.14M
March 31, 2020 -376.81M
December 31, 2019 -338.43M
September 30, 2019 -254.76M
June 30, 2019 -203.71M
March 31, 2019 -117.78M
December 31, 2018 -98.84M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
cbdMD, Inc. -2.409M
SNDL, Inc. 36.88M
Clearmind Medicine, Inc. -6.997M
CannaPharmaRx, Inc. -0.1674M
Cosmos Health, Inc. -14.83M